Siegal Jonathan reported option exercise involving 1,500 derivative units of Vericel Corp at $0.00 for $0 on Nov 5, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Principal Accounting Officer
Principal Accounting Officer
Filed Nov 6, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
1,500Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
1,198Direct
Trade date
Nov 5, 2026Option exercise
Filed
Nov 6, 2026, 4:05 PM ET1-day reporting delay
Accession
0001140361-26-042463Code M · Transaction 394649
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 5, 2026Option exercise1,500$34.90$52,350Trade 394647
Nov 5, 2026Sell1,500$52.90−$79,350Trade 394648
3 transaction rows in this filing. Joint filers share the same rows.

VCEL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
VCEL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −27%1w ago −21%1d ago −21%
Returns since7d +4.3%30d90d180d1y

Footnotes in full

F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025. F3: These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted